维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Fremes SE"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Im pact of preoperative risk and perioperative morbidity on ICU stay following coronary bypass surgery显示文摘	Christakis GT Fremes SE Naylor CD	1996	Cardiovasc Surg1996，4，1：	1
2	Aprotinin and tranexamic acid for high transfusion risk cardiac surgery 显示文摘	Wong BI McLean RF Fremes SE	2000	Ann Thorac Surg2000，69，3：	1
3	Apro- tinin and tranexamic acid for high trans- fusion risk cardiac surgery显示文摘	Wong BI McLean RF Fremes SE	2000	Ann Thorac Surg2000，69，3：	1
4	Coronary artery bypass grafting in patients with poor ventricular function 显示文摘	Christakis GT Weisel RD Fremes SE	1992	J Thorac Cardiovasc Surg1992，103，：	1
5	Aprotinin and tranexamic acid for high transfusion risk cardiac surgery显示文摘	Wong BI McLean RF Fremes SE	2000	Ann Thorac Surg2000，69，3：	1
6	Gender differences in outcomes after hospital discharge from coronary artery bypass grafting 显示文摘	Curu V Fremes SE	2006	Circ J2006，31，4：	1
7	Phase 1 human trial of adenosine-potassium cardioplegia显示文摘	Fremes SE Levy SL Christakis GT	1996	Circulation1996，94，9：	1
8	Antithrombotic and thromb- olytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines显示文摘	Whitlock RP Sun JC Fremes SE	2012	Chest2012，141，2：	1
9	Gender differences in outcomes after hospital discharge from coronary artery bypass grafting显示文摘	Guru V Fremes SE Austin PC	2006	Circulation2006，113，4：	1
10	Antithrombotic andthrombolytic therapy for valvular disease: Antithrombotic Therapy andPrevention of Thrombosis, 9th ed: American College of Chest Physi-cians Evidence-Based Clinical Practice Guidelines 显示文摘	Whitlock RP Sun JC Fremes SE	2012	Chest2012，141，2：	1
11	Antithrombotic and thrombolytic therapy for valvular disease:antithrombotic therapy and prevention of thrombosis,9th ed:American college of chest physicians evidence-based clinical practice guidelines显示文摘	Whitlock RP Sun JC Fremes SE	2012	Chest2012，141，2：	1
12	Hemodynamic and myocardial metabolic consequences of PEEP显示文摘	Tittley JG Fremes SE Weisel RD	1985	Chest1985，88，4：	1
13	Coronary by pass and carotid endarterectomy: does a combined app rocach increase risk? A metaanalysis显示文摘	Fremes SE Weisel RD	1999	Ann Thorac Surg1999，68，1：	1
14	Gender differences in outcomes after hospital discharge from coronary artery bypass grafting显示文摘	Curu V Fremes SE	2006	Circ J2006，31，：	1
15	Warm heart investisators, randomized trial of normathermic versus hypothermic coronary bypass surgery显示文摘	Lictenstein SV Fremes SE	1994	Lancet1994，343，6：	1
16	Anfithrombotic and thrombolytic therapy for valvular disease:Antithmmbotic Therapy and Prevention of Thrombosis,9th ed:Ameriean College of Chest Physicians Evidence-Based Clinical Practice Guidelines显示文摘	Whitlock RP Sun JC Fremes SE	2012	Chest2012，141，2：	1
17	Gender differences in outcomes after hospital discharge from coronary artery bypass grafting显示文摘	Curu V Fremes SE	2006	Circ J2006，31，：	1
18	The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy显示文摘	Guru V Fremes SE	2004	Clin Nephrol2004，62，2：	1
19	Cardiac release of protacyclin and thromboxane A2 during coronary revascularization 显示文摘	Teoh KH Fremes SE Weisel RD	1987	J Thorac Cardiovasc Surg1987，93，1：	1
20	Anfithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines显示文摘	Whitlock RP San JC Fremes SE et at	2012	Chest2012，141，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示